NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study

Por Leal, Alexis D., Qin, Rui, Atherton, Pamela J., Haluska, Paul, Behrens, Robert J., Tiber, Charles, Watanaboonyakhet, Patanit, Weiss, Matthias, Adams, Paul T., Dockter, Travis, Loprinzi, Charles L.
Publicado em 2014

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial

Por Holtan, Shernan G., Steen, Preston D., Foster, Nathan R., Erlichman, Charles, Medeiros, Fabiola, Ames, Matthew M., Safgren, Stephanie L., Graham, David L., Behrens, Robert J., Goetz, Matthew P.
Publicado em 2012

Assessment of Long-Term Rectal Function in Patients Who Received Pelvic Radiotherapy: A Pooled North Central Cancer Treatment Group Trial Analysis, N09C1

Por Brown, Lindsay C., Atherton, Pamela J., Neben-Wittich, Michelle A., Wender, Donald B., Behrens, Robert J., Kozelsky, Timothy F., Loprinzi, Charles L., Haddock, Michael G., Martenson, James A.
Publicado em 2013

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

Por Mc Kean, Heidi, Stella, Philip J., Hillman, Shauna L., Rowland, Kendrith M., Cannon, Michael W., Behrens, Robert J., Gross, Gerald G., Sborov, Mark D., Friedman, Eliot L., Jatoi, Aminah
Publicado no Cancer Invest (2011)

North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane

Por Sideras, Kostandinos, Dueck, Amylou C., Hobday, Timothy J., Rowland, Kendrith M., Allred, Jacob B., Northfelt, Donald W., Lingle, Wilma L., Behrens, Robert J., Fitch, Tom R., Nikcevich, Daniel A., Perez, Edith A.
Publicado em 2012

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

Por Srivastava, Geetika, Renfro, Lindsay A., Behrens, Robert J., Lopatin, Margarita, Chao, Calvin, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, J. Philip, Kim, George, Mazurczak, Miroslaw, Lee, Mark, Alberts, Steven R.
Publicado em 2014

Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)

Por Boora, Ganesh K., Kulkarni, Amit A., Kanwar, Rahul, Beyerlein, Peter, Qin, Rui, Banck, Michaela S., Ruddy, Kathryn J., Pleticha, Josef, Lynch, Cynthia A., Behrens, Robert J., Züchner, Stephan, Loprinzi, Charles L., Beutler, Andreas S.
Publicado no J Neurol Sci (2015)

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Por Alberts, Steven R., Yu, Tiffany M., Behrens, Robert J., Renfro, Lindsay A., Srivastava, Geetika, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, John P., Kim, George P., Mazurczak, Miroslaw A., Hornberger, John
Publicado no Pharmacoeconomics (2014)

Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group study N0074 ()

Por Uhm, Joon H., Ballman, Karla V., Wu, Wenting, Giannini, Caterina, Krauss, JC, Buckner, Jan C., James, C.D, Scheithauer, Bernd W., Behrens, Robert J., Flynn, Patrick J., Schaefer, Paul L., Dakhill, Shaker R., Jaeckle, Kurt A.
Publicado no Int J Radiat Oncol Biol Phys (2010)

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

Por Siziopikou, Kalliopi P., Anderson, Stewart J., Cobleigh, Melody A., Julian, Thomas B., Arthur, Douglas W., Zheng, Ping, Mamounas, Eleftherios P., Pajon, Eduardo R., Behrens, Robert J., Eakle, Janice F., Leasure, Nick C., Atkins, James N., Polikoff, Jonathan A., Seay, Thomas E., McCaskill-Stevens, Worta J., Rabinovitch, Rachel, Costantino, Joseph P., Wolmark, Norman
Publicado no Breast Cancer Res Treat (2013)